How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine

RATIONALE: Atherosclerotic cardiovascular disease (ASCVD), including coronary heart disease (CHD), atherosclerotic stroke and peripheral vascular disease, has become the most deadly chronic noncommunicable disease throughout the world in recent decades, while plaque regression could reduce the occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Dong, Xu, Xiang-Ru, Yue, Bo-Wen, Zhao, Li-Li, Yan, Shi-Hai, Qian, Yu-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824820/
https://www.ncbi.nlm.nih.gov/pubmed/31651893
http://dx.doi.org/10.1097/MD.0000000000017664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824820/
https://www.ncbi.nlm.nih.gov/pubmed/31651893
http://dx.doi.org/10.1097/MD.0000000000017664

Ejemplares similares